Fair Value Calculator Fair Value Calculator
EN DE

FRASER (FRASER) Fair Value & Analysis

IN · Market cap ₹82.1M

F FRASER FRASER · BSE
Price₹10.11
Fair Value₹3.90
Upside-61.4%
Quality64/100
Watch FRASER for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹2.64 – ₹5.15

Fair value as of: Jul 5, 2026

From 7 valuation models · updated today

Share price −14.5% over the past month.

Price vs Fair Value (12 months)

₹11.96 ₹7.08 Fair Value ₹3.90 Jul 2025 Jul 2026

12‑month range ₹7.08 – ₹11.96 · fair‑value band ₹2.64 – ₹5.15 · the ₹10.11 price screens above the ₹3.90 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

FRASER (FRASER) currently trades at ₹10.11, while our model-based Fair Value estimate is ₹3.90 — implying the stock looks roughly 61.4% overvalued today. We read business quality at 64/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, FRASER generated revenue of ₹13.6M at a net margin of -45.1%. It earns a return on equity of -12.2%. Net debt stands at ₹2.5M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹2.64 (bear case) to ₹5.15 (bull case); at ₹10.11, the current price sits above that range. The share trades about 19% below its 52-week high and 48% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹13.6M
Revenue growth (YoY) -98.2%
Net margin -45.1%
Return on equity -12.2%
Free cash flow ₹5.5M FY2026
Operating margin -74.5%
More key figures
EPS (TTM) ₹-0.7600
Net debt ₹2.5M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

FRASER reported revenue of ₹13.6M in FY2026 versus ₹491M in FY2022, a compound −59.2%/yr. Reported net income was −₹6.2M in FY2026.

Revenue −59.2%/yr
FY22 ₹491M
FY23 ₹128M
FY24 ₹273K
FY25 ₹2.2M
FY26 ₹13.6M
Net income
FY22 ₹11.6M
FY23 ₹3.4M
FY24 −₹10.5M
FY25 −₹15.8M
FY26 −₹6.2M

Is FRASER fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "FRASER Fair Value". https://www.fairvalue-calculator.com/stock/FRASER

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is FRASER (FRASER) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹3.90 versus a price of ₹10.11 — about −61% (overvalued). Model-based estimate, not financial advice.
What is the fair value of FRASER?
Our model-based fair value for FRASER is ₹3.90 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹10.11.
What is the quality score of FRASER?
FRASER has a Quality Score of 64/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of FRASER (FRASER)?
FRASER reported trailing-twelve-month revenue of about ₹13.6M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of FRASER?
The net profit margin of FRASER is about -45.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.